Discussion on the Focus of On-site Inspection of Clinical Trials of Lung Cancer
Targeted Therapy and Immunotherapy Drugs / 中国肺癌杂志
Chinese Journal of Lung Cancer
;
(12): 506-510, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-939739
ABSTRACT
As lung cancer targeted therapy and immunotherapy drugs are the current hot spot in the research and development area of new anti-tumor drugs, the amount of clinical trial in this area is increasing year by year. On the basis of combing the on-site inspections of drug registration clinical trials from 2019 to 2021, combined with the characteristics of lung cancer targeted therapy and immunotherapy drugs, this paper discusses the focus of on-site inspection of clinical trials of such drugs, and puts forward suggestions for the compliant implementation of lung cancer clinical trials.
.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Molecular Targeted Therapy
/
Immunologic Factors
/
Immunotherapy
/
Lung Neoplasms
/
Antineoplastic Agents
Limits:
Humans
Language:
Chinese
Journal:
Chinese Journal of Lung Cancer
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS